Deal details and current status
Manchester City have moved to resolve their midfield vacancy following the departure of Rodri to Barcelona, reaching an agreement in principle with Chelsea for the transfer of Enzo Fernandez. Reports from AS and Football Transfers suggest the fee is approximately €140 million (£120 million), a figure that would represent a significant Premier League outlay for a midfielder. Fernandez, 25, is expected to sign a five-year contract at the Etihad Stadium, with the option for an additional season included in the agreement.
While the transfer has progressed to advanced stages, it remains subject to final documentation and the completion of a medical examination. According to reporting from TEAMtalk, sources have indicated that while Fernandez has made his desire to move clear, Chelsea have cautioned that they retain the right to keep the player if final terms are not met to their satisfaction before the deadline.
Strategic rationale and squad impact
The pursuit of the Argentina international highlights Manchester City's urgent requirement for technical security in the central third. Rodri’s exit left a void in the base of Pep Guardiola's midfield that has proved difficult to fill, with Fernandez identified as the primary candidate to provide similar progression and tactical discipline. The move marks a dramatic shift from Chelsea's recruitment landscape, where the midfielder arrived from Benfica in 2023 for £107 million.
Under Xabi Alonso, Chelsea’s tactical direction has evolved, with the manager periodically rotating the midfield and occasionally leaving Fernandez out of early-season fixtures. This development reflects a broader recalibration of the squad, as the London club looks to balance their financial commitments while reshaping the engine room. Consequently, Chelsea have already identified potential cover, with Roma’s Manu Koné emerging as a primary target to address the immediate loss of squad depth. Whether this transaction crosses the final threshold before the window closes remains the primary obstacle, as Chelsea continue to weigh the benefits of a significant capital injection against the disruption to their squad balance.
